We are excited to have this trial open for patients with #metastatic #breastcancer treated an NCI community oncology practices #NCORP
ECOG-ACRIN Cancer Research Group Antonio Wolff, MD (#HealthPolicyIsEconomicPolicy) Ruth Carlos Ilana G Lynne I Wagner PhD

#ClinicalTrial EAQ221CD/CONCURxP monitors CDK4/6 inhibitor medication use with text message reminders & alerts for patients treated for #BreastCancer . For more information: bit.ly/EAQ221CD #bcsm cc: Gelareh Sadigh, MD, Ilana G

Trial Activation: EA7211/STRASS 2, led by Daniel Barboriak, MD of Duke Health, is a phase II study of identifying findings on brain scans that could help make better predictions about #BrainCancer progression. Learn more from our recent newsletter article: blog-ecog-acrin.org/now-enrolling-…

Trial is open and we look for more sites! Appreciate support to help pts with UTUC! ECOG-ACRIN Cancer Research Group Jean Hoffman-Censits SWOG Cancer Research Network Alliance for Clinical Trials in Oncology NRG Oncology Sia Daneshmand, M.D. Thomas Flaig Joshua Meeks Jonathan Rosenberg MD Matt Milowsky Roger Li Dr. John Sfakianos Sarah P. Psutka MD MS Ashish M. Kamat, MD, MBBS Yousef Zakharia Kriti Mittal, MD

#ClinicalTrial EA2205, led by David Hsieh MD, is a randomized phase 2 study for cHCC-CC – a rare form of primary #LiverCancer . For more information, click here: bit.ly/EA2205 cc: Shaalan Beg MD MBA FASCO, American Liver Foundation National, Cholangiocarcinoma Foundation

Kudos to Sanford Health for enrolling their first patient in #ClinicalTrial EA5182. This study explores AZD9291 (osimertinib) with or without bevacizumab as initial treatment for patients with EGFR-mutant #LungCancer . bit.ly/ea5182 cc: Helena Yu, Balazs Halmos #LCSM

#ClinicalTrial EA2222/PUMP, led by Michael Lidsky, MD, FACS, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: bit.ly/ea2222-pump cc: Michael D’Angelica, Shishir K. Maithel, Andrea Cercek

EA8192, led by Jean Hoffman-Censits and Petros Grivas, is a phase II/III #clinicaltrial of durvalumab and chemotherapy for patients with high grade upper tract urothelial cancer prior to nephroureterectomy. For more: bit.ly/ea8192-trial #blcsm

The EA8211/SOAR clinical study is testing a new treatment approach for patients with #KidneyCancer that has spread to 2-5 other places in the body. Learn more: bit.ly/ea8211-study #kcsm

#ClinicalTrial EAQ211/The AYA Social Genomics Study, led by Brad Zebrack of U-M Rogel Cancer Center & University of Michigan School of Social Work, aims to improve care for #AYAs diagnosed with and treated for #lymphoma . Learn more: bit.ly/eaq211-study #AYACancer #AYACSM

You may be eligible to participate in a #prostatecancer study, EA8191/INDICATE, for patients with post-prostatectomy recurrence. Learn more: bit.ly/ea8191indicate #pcsm #ProstateCancerAware cc: @nehavapiwala

EA2197 is a randomized phase 2/3 #ClinicalTrial assessing the optimal perioperative approach for patients with incidental #GallbladderCancer . Learn more: bit.ly/EA2197 cc: Shishir K. Maithel Winship Cancer Institute of Emory University

EA9152 is a phase Ib/II study of venetoclax in combination with vincristine sulfate in patients with relapsed or refractory T-cell or B-cell #ALL . For more information: bit.ly/EA9152 #leukemia #leusm cc: SelinaLuger

Do you have #HER2positive #BreastCancer ? If so, you may be eligible to participate in the phase 2 #ClinicalTrial EA1211/DIRECT, testing if FDG-PET/CT imaging can better predict a patient's response to treatment than the usual approach. Learn more: bit.ly/EA1211

Imagine a future where #breastcancer screening is tailored to your individual risk factors. The TMIST trial could help make this possible. Learn more: bit.ly/tmist #bcsm #TMIST4BC cc: American College of Radiology NCI Prevention & Early Detection

Learn about the EA2192/APOLLO study, treating patients with #PancreaticCancer that has been surgically removed and has a BRCA1, BRCA2, or PALB2 mutation. More information: bit.ly/apollo-trial #pancsm #pancaware

Dr. Lucille Adams-Campbell Georgetown Lombardi shares poignant memories about the late Dr. Worta McCaskill-Stevens National Cancer Institute as a post-humous lifetime achievement award is presented to her son, Saleh Stevens, for championing #InclusiveParticipation in #ClinicalTrials #NCORP . #AACR24

Lucile Adams-Campbell presents the AACR Distinguished Public Service Award posthumously to Worta McCaskill-Stevens during the #AACR24 Opening Ceremony. Dr. McCaskill-Stevens’ son, Saleh Stevens, accepted the award on her behalf.

Researchers are studying if patients with cHCC-CC have better results from treatment with #chemotherapy plus drugs that help the body’s immune system fight cancer. Learn more on #ClinicalTrial EA2205 here: bit.ly/EA2205 #LiverCancer

In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients with unresectable #ColorectalCancer liver metastases. For more: bit.ly/ea2222-pump cc : Michael D’Angelica, Shishir K. Maithel, Andrea Cercek